Compare Novo Nordisk A/S (NVO) vs Snap On Incorporated (SNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Snap On Incorporated — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Snap On Incorporated trades at $402.3 (market cap $21.06B). The key difference: Novo Nordisk A/S is far larger — about 10.5× Snap On Incorporated's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | SNA | |
|---|---|---|
Market Cap | $220.53B | $21.06B |
Sector | Health | Technology |
52-Week High | $71.70 | $414.97 |
52-Week Low | $35.29 | $317.79 |
Enterprise Value | $239.49B | $20.58B |
Dividend Yield | 3.63% | 2.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →
